These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19699489)

  • 1. Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia.
    Martins-de-Souza D
    J Psychiatr Res; 2010 Feb; 44(3):149-56. PubMed ID: 19699489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a functional single nucleotide polymorphism in the 2',3'-cyclic nucleotide 3'-phosphodiesterase gene on the expression of oligodendrocyte-related genes in schizophrenia.
    Iwamoto K; Ueda J; Bundo M; Nakano Y; Kato T
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):103-8. PubMed ID: 18289148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: a genetic perspective (review).
    Shastry BS
    Int J Mol Med; 2002 Mar; 9(3):207-12. PubMed ID: 11836624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in postmortem pathology and neurochemistry in schizophrenia.
    Dean B; Boer S; Gibbons A; Money T; Scarr E
    Curr Opin Psychiatry; 2009 Mar; 22(2):154-60. PubMed ID: 19553869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.
    Stewart DG; Davis KL
    Int Rev Neurobiol; 2004; 59():381-424. PubMed ID: 15006496
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.
    Corfas G; Roy K; Buxbaum JD
    Nat Neurosci; 2004 Jun; 7(6):575-80. PubMed ID: 15162166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myelin-pathogenesis puzzle in schizophrenia: a literature review.
    Karoutzou G; Emrich HM; Dietrich DE
    Mol Psychiatry; 2008 Mar; 13(3):245-60. PubMed ID: 17925796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in schizophrenia.
    Thaker GK; Carpenter WT
    Nat Med; 2001 Jun; 7(6):667-71. PubMed ID: 11385502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the neurobiology of schizophrenia.
    Miyamoto S; LaMantia AS; Duncan GE; Sullivan P; Gilmore JH; Lieberman JA
    Mol Interv; 2003 Feb; 3(1):27-39. PubMed ID: 14993436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics.
    Martins-de-Souza D; Harris LW; Guest PC; Bahn S
    Antioxid Redox Signal; 2011 Oct; 15(7):2067-79. PubMed ID: 20673161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia.
    Wang L; Lockstone HE; Guest PC; Levin Y; Palotás A; Pietsch S; Schwarz E; Rahmoune H; Harris LW; Ma D; Bahn S
    J Proteome Res; 2010 Jan; 9(1):521-7. PubMed ID: 19916557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery in psychiatric disorders.
    Schwarz E; Bahn S
    Electrophoresis; 2008 Jul; 29(13):2884-90. PubMed ID: 18512679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry].
    Pezard L; Nandrino JL
    Encephale; 2001; 27(3):260-8. PubMed ID: 11488256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia: diverse approaches to a complex disease.
    Sawa A; Snyder SH
    Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1999; 60 Suppl 12():9-12. PubMed ID: 10372603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from spatially mapped gene expression in the mouse brain.
    Sunkin SM; Hohmann JG
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R209-19. PubMed ID: 17911164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of synaptic connectivity reduction for pathogenesis, clinical picture and course of schizophrenia].
    Rabe-Jabłońska J
    Psychiatr Pol; 2003; 37(6):951-64. PubMed ID: 14727368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating transcriptome, proteome and glycome analyses of Schistosoma biology.
    Hokke CH; Fitzpatrick JM; Hoffmann KF
    Trends Parasitol; 2007 Apr; 23(4):165-74. PubMed ID: 17336161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
    Huang JT; Wang L; Prabakaran S; Wengenroth M; Lockstone HE; Koethe D; Gerth CW; Gross S; Schreiber D; Lilley K; Wayland M; Oxley D; Leweke FM; Bahn S
    Mol Psychiatry; 2008 Dec; 13(12):1118-28. PubMed ID: 17938634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling in schizophrenia and related mental disorders.
    Iwamoto K; Kato T
    Neuroscientist; 2006 Aug; 12(4):349-61. PubMed ID: 16840711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.